MAG / Siglec-4a

MAG / Siglec-4a

MAG / Siglec-4a 詳細

Molecule Name
Myelin-associated glycoprotein
分子の別称
MAG,Siglec-4a,GMA,S-MAG
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
MAG,Siglec-4a,GMA,Sialic Acid Binding Ig-Like Lectin 4A,Myelin-Associated Glycoprotein,SIGLEC4A,S-MAG,SPG75,Myelin Associated Glycoprotein,Sialic Acid-Binding Immunoglobulin-Like Lectin 4A
バックグランド
Myelin-associated glycoprotein (MAG), a nervous system cell adhesion molecule, is an I-type lectin that binds to sialylated glycoconjugates, including gangliosides bearing characteristic structural determinants. Preferentially binds to alpha-2,3-linked sialic acid. Binds ganglioside Gt1b. Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2. Protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2. In dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides. In cerebellar granule cells the inhibition is mediated primarily via binding to neuronal gangliosides. In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides.

MAG / Siglec-4a 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AXER-204AXER-204Phase 2 ClinicalRenetx Bio Inc
Cardiovascular Diseases
詳細